Search
-
New#NewAseBioMember | "AseBio represents the natural meeting point of the biotech ecosystem i...
Meet Atlas Molecular Pharma, our new member. We spoke with Susana Castel, CEO.
-
NewGENESIS Biomed leads the European PHEMS Business Hackathon in Barcelona to shape the fut...
The event brought together experts from hospitals, research organizations, industry and innovation ecosystems to co-create sustainable service models for the Paediatric Health Data Space (PHDS).
-
NewU.S. announces pharmaceutical tariffs under Section 232: what it means for biotech compani...
At AseBio, we believe this Executive Order creates uncertainty for the European biotechnology sector—especially for companies exporting to the U.S.—and we will continue working to help our member
-
NewHIPRA awarded by the Ministry of Industry with the ‘Bien Hecho en España’ prize for its co...
The company received the recognition from the Ministry of Industry, presented by King Felipe VI, for its commitment to biotechnological innovation, industrial capacity and strengthening Europe’s
-
NewHIPRA marks the first year of its CDMO with a first strategic contract
HIPRA Biotech Services reaches key milestones in its first year of operations, including signing its first agreement in just nine months and advancing new collaboration opportunities with European
-
CompanyBiopredX Predicciones Biólogicas
-
NewThe new Kadans Science Partner building in Spain is being inaugurated: Node I at Málaga Te...
The Kadans Tech Summit is an exclusive event bringing together European deep tech companies, technology leaders, academics and researchers.
-
NewBiobide obtains two ENAC GLP certifications and expands its capacity to conduct studies fo...
Biobide, a subsidiary of Biotechnology Assets (BME Growth: BST), has obtained two Good Laboratory Practice (GLP) certifications granted by ENAC for chemicals, food additives and plant protection
-
NewNatac’s CEO presents SustaiNext as an example of industrial scale-up at the CBE JU Stakeho...
Antonio Delgado participated in the panel “ From lab to fab: enabling scale up of bio-based innovations”
-
NewAseBio joins the manifesto led by EuropaBio in support of Biotech Act II, crucial for biom...
We consider a Biotech Act II that improves coordination, facilitates market access, and accelerates industrial development to be key in transforming European scientific potential into economic
-
NewBCN HEALTH publishes a systematic review highlighting the substantial economic burden of h...
BCN HEALTH has published the study “Economic burden of heart failure in Europe: A systematic review of costs and cost-effectiveness” in ESC Heart Failure, a peer-reviewed journal of the European
-
NewSalamanca will become the national epicenter of the bioeconomy with the celebration of the...
The city of Salamanca reinforces its position as a strategic enclave for the bioeconomy and agri-food innovation in Castilla y León, hosting a meeting that aims to place the territory on the European